WSL
INBX icon

Western Standard LLC’s Inhibrx INBX Stock Holding History

Western Standard LLC’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45M Buy
+47,000
New +$4.71M 1.51% 19

Other funds holding INBX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Western Standard LLC's INBX Position: Q2 2026 in Review

Western Standard LLC opened a new position in Inhibrx (INBX) in Q2 2026: 47,000 shares worth $4.45M. The stake represents 1.51% of the portfolio and ranks #19 among its holdings.

53 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Western Standard LLC held 47,000 shares of Inhibrx worth $4.45M as of Q2 2026.
  • Inhibrx was a new Western Standard LLC position in Q2 2026.
  • Inhibrx made up 1.51% of Western Standard LLC's portfolio in Q2 2026, its #19 holding.
  • 53 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Western Standard LLC's 13F filing for Q2 2026, filed 10 Aug 2026.